Thrilled to begin my new role as SoMe editor at #EHJCVI! Excited to help share the latest advancements in cardiovascular imaging research! Grateful to @EHJCVIEiC, @JGrapsa, and @EZancanaroMD for the trust and opportunity!

#EHJCVI🫀 3D RegFr sharpens TR assessment, reflecting the true hemodynamic burden by “normalizing” for lower right-sided pressures, loading conditions, and RV size/function. Updated corrected PISA refine grading, with RegFr ≥27% marking increased risk 👉 https://t.co/8JgvBdYqyR

#EHJCVI 🫀Check out HeartAge, a CMR-based ML model that turns routine metrics into CV “biological age" 🗓️ A higher HeartAge-gap flagged more CV events in both sexes and higher all-cause mortality in women, driven largely by aortic distensibility 👉 https://t.co/bA4WUzGvEe

#EHJCVI 🩻 How much radiation comes from cardiac procedures? They account for 30–50% of all medical exposure, with doses up to 194 mSv (≈ 9700 chest X-rays). Excess cancers appear 3–12 years post-exposure. Should it be included as an endpoint in RCT? 👉 https://t.co/g8g6U6HS6L

3 years and hundreds of hours of hard work behind this important multicenter study 📚 Results in 2026 🙏 Really grateful to all collaborators and those who have supported this important initiative @ShehabAnwer @pabloplopez_ @AliElzieny @naeimhos @andgiannopmd @alessia_gimelli

Honored to be part of the wonderful VHD-W registry, working to address gender disparities in valvular heart disease management 📊 We are the first study assessing gender disparities in VHD, aiming to examine them through treatment patterns, guideline adherence, and clinical

#EHJCVI 🩺 4D Flow CMR is redefining fetal CHD assessment. In 3rd-trimester fetuses, it provides hemodynamic insights in 51% of cases of CHD, strengthening perinatal planning and risk stratification in complex CHD ✨ Read more 👉 https://t.co/MlHH2glu9V

#EHJCVI 🫀ICD selection in NICM isn’t just about LVEF <35% or LGE %, location matters 📌 Midwall LGE identifies patients with higher MAACE risk ⚡DERIVATE Risk Score 2.0 (LGE location + LVEF + sex) delivers a +54% NRI vs LVEF alone. Read more 👉 https://t.co/rF396dN85g

🫀 3D echo is taking center stage in routine #ACHD care ✨ It delivers precise anatomical visualization, accurate LV/RV volumes & EF, en-face valve assessment, and sharper regurgitation quantification. A key tool for planning and procedural guidance 🔍 👉 https://t.co/v2YH2YWis9

#EHJCVI 🫀 In the Copenhagen Baby Heart Study (>25,000 newborns), 1st relatives 👶 with BAV showed a 3x prevalence of BAV/aortopathy and a 12x BAV risk compared with the general population, supporting family screening and follow-up 🔎 👉 Read more: https://t.co/8XEMptIm6W

#EHJCVI 🤔 85-year-old man with acute right leg pain and DVT. No history of AF, ECG in sinus rhythm. TEE demonstrates a highly mobile string-like thrombus in the left atrium / left ventricle (panel B). No PFO on TEE. Follow-up CT shows this (panels C and D): 👀

#EHJCVI 🧒 When should stress imaging be used in pediatrics and CHD? This review outlines key protocols and clinical applications across CAD, HCM, VHD, aortic coarctation, diastolic dysfunction, and PH 📚🔍 👉 Read more: https://t.co/68cBXijgr8

#EHJCVI 🫀 Can RV myocardial work help identify PAH patients at higher risk? 📊 RV global wasted work correlates with mPAP, PVR, SVC, and PAC, with higher values in high-risk groups. A cut-off >175 mmHg% is associated with mortality ⚠️ Read more: https://t.co/XzGlnn6OjP

#EHJCVI 🩻 In diabetic patients, does OCT-based thin-cap fibroatheroma risk detection recalibrate risk enough to justify intervention? 🔍 This editorial discusses the value of preventive focal sealing of vulnerable plaques and its implications 👉 https://t.co/WNsBarERgc

#EHJCVI 🫀 Curious about the differences in diastolic dysfunction guidelines across societies? 📖 This editorial by @jgrapsa, @argulian, @OttoSmiseth unpacks key differences and their clinical impact 👉 Read more: https://t.co/U0GlK0n1XI #EchoFirst #CVImaging #Echocardiography

#EHJCVI 🫀 Curious about the differences in diastolic dysfunction guidelines across societies? 📖 This editorial by @jgrapsa, @argulian, @OttoSmiseth unpacks key differences and their clinical impact 👉 Read more: https://t.co/8GLI7JVYSn #EchoFirst #CVImaging #Echocardiography

#EHJCVI 🚀 A new accelerated stress-perfusion CMR protocol shows non-inferior per-vessel diagnostic accuracy (<5%) and comparable per-patient accuracy, saving over 20 min per scan. Could this be the future for evaluating suspected angina? 🫀 👉 Read more: https://t.co/9lhJ3Edpnq

Empowering the next generation of congenital heart surgeons through advanced imaging and 3D cardiac models — helping to reduce global inequalities in CHD care and improve outcomes for children worldwide. 🫀✨ #Cardiology #HeartHealth https://t.co/O99croEE3p

JACC: BTS call for cardio-immunology 📣 ❤️‍🔥 https://t.co/6c3w4RTYP2 ❤️‍🔥 immune cells in CVD ❤️‍🔥 Immune-stromal cell interactions ❤️‍🔥 how do cardiovascular risk factors, including metabolism, influence the immune system? ❤️‍🔥 immune system in cardiovascular development and regeneration

Post-MI immunomodulation ❤️‍🔥 are we on our way to a clinical trial? CD14 Blockade Modulates Macrophage-Mediated Immunological Injury in a Translational Model of Reperfused ST-Segment Elevation Myocardial Infarction | JACC: Basic to Translational Science

#EHJCVI 🧬 Should Lp(a) be considered a biomarker of bioprosthetic valve vulnerability? Elevated Lp(a) emerges as an independent predictor of structural valve degeneration, particularly in stenotic/mixed phenotypes 🫀🔍 👉 Read more: https://t.co/FrKIN17tdD